Within this action to support Personalized Precision Medicine are various measures.
OE1A1.1: ISCIII Call for Personalized Precision Medicine
El objetivo de esta convocatoria es fomentar el despliegue progresivo de la medicina personalizada de precisión en el sistema sanitario mediante la financiación de proyectos de I+D+I.
OE1A1.2: Joint Missions of the Ministry of Science and Innovation and Ministry of Health - Personalized Precision Medicine: Genomics
This call is connected with the previous actions of Personalized Precision Medicine, as well as with the Precision Medicine Infrastructure associated with Science and Technology – IMPaCT (impact.isciii.es). Genomic medicine represents a diagnostic and therapeutic opportunity for many patients and their families. This call is aimed at the design and implementation of Genomic Medicine programs integrated into the National Health System (SNS), as well as its evaluation in terms of health policy.
OE1A1.3: Joint Missions Ministry of Science and Innovation and Ministry of Health - Diagnostic Medicine ALS and Rare Diseases
The diagnostic procedure of many rare diseases, neuro-muscular and Amyotrophic Lateral Sclerosis (ALS) is especially complex. This circumstance can cause a high clinical, social and economic impact. Through this call it is intended to facilitate the implementation of coordinated actions that allow the assistive implementation of innovation in diagnostic, therapeutic and rehabilitative procedures in these patients.
OE1A1.4: Joint action ISCII-CDTI- Transmissions 2023
Through this call, R&D projects in the field of health are funded that allow to obtain early and more accurate diagnoses, innovative and personalized treatments, and/or improvements in the follow-up and rehabilitation of people. The projects aim to generate a result of industrial and/or business applicability. Companies and research centers and agencies from the National Health System (SNS) environment are jointly involved.
OE1A1.5: Joint action AEI-CDTI-Transmissions 2024
Through this call, projects are funded in public-private collaboration and sharing leadership to address the challenges related to infectious diseases and microbial resistance.
